ZNF420 is a transcription factor containing 19 C2H2-type zinc fingers and a KRAB domain, implicated in transcriptional regulation and p53-mediated apoptosis . The FITC-conjugated ZNF420 antibody enables direct visualization of this protein in cellular and tissue samples, leveraging fluorescein’s fluorescent properties for techniques like immunofluorescence (IF) and immunohistochemistry (IHC).
Labeling Impact: Higher FITC-to-antibody ratios reduce binding affinity due to steric hindrance but increase sensitivity in low-abundance targets .
Optimal Conjugation: Achieved at pH 9.5, 25 mg/mL antibody concentration, and 30–60 minutes at room temperature, yielding an F/P (fluorescein-to-protein) ratio of 2–4 .
Non-Specific Staining: Over-conjugated antibodies (>6 FITC molecules per IgG) show increased background noise .
Biological Role: ZNF420 acts as a negative regulator of p53 under non-stress conditions. Phosphorylation by ATM during DNA damage dissociates ZNF420 from p53, enabling apoptosis .
Chromatin Organization: ZNF420 interacts with chromatin-modifying complexes, influencing gene expression in development and cancer .
Immunofluorescence: Validated in cultured cells and paraffin-embedded mouse tissues, showing nuclear localization of ZNF420 .
Cross-Reactivity: Confirmed reactivity with human, rat, and cow homologs via sequence alignment .
Controls Required: Include unstained samples and isotype-matched antibodies to mitigate Proclin 300-induced autofluorescence .
| Conjugate | Excitation/Emission (nm) | Sensitivity | Non-Specific Staining Risk |
|---|---|---|---|
| FITC | 490/525 | Moderate | High (if over-conjugated) |
| AbBy Fluor® 594 | 590/617 | High | Low |
| HRP | N/A | High | Moderate |